Mithilesh Lal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mithilesh Lal has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anton Hubertus van Kaam
Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, Amsterdam, Netherlands
1 shared publication - Carlos Fajardo
Department of Pediatrics, Cumming School of Medicine, University of Calgary Foothills Medical Centre, 1403 29 St NW, Calgary, AB, T2N 2T9, Canada
1 shared publication - Gianluca Lista
Department of Neonatology and Neonatal Intensive Care Unit, V. Buzzi Children’s Hospital, 20154 Milan, Italy
1 shared publication - Helmut D. Hummler
Department of Neonatology, University Children’s Hospital Tuebingen, 72076 Tuebingen, Germany
1 shared publication - Karel Roubík
Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic
1 shared publication Prakash Loganathan
Neonatal Intensive Care Unit, South Tees Hospitals National Health Service (NHS) Foundation Trust, James Cook University Hospital, Middlesbrough, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 22 June 2022
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 10, 915312
Automated Oxygen Delivery in Neonatal Intensive Care
Oxygen is the most common drug used in the neonatal intensive care. It has a narrow therapeutic range in preterm infants. Too high (hyperoxemia) or low oxygen (hypoxemia) is associated with adverse neonatal outcomes. It is not only prudent to maintain oxygen saturations in the target range, but also to avoid extremes of oxygen saturations. In routine practice when done manually by the staff, it is challenging to maintain oxygen saturations within the target range. Automatic control of oxygen delivery is now feasible and has shown to improve the time spent with in the target range of oxygen saturations. In addition, it also helps to avoid extremes of oxygen saturation. However, there are no studies that evaluated the clinical outcomes with automatic control of oxygen delivery. In this narrative review article, we aim to present the current evidence on automatic oxygen control and the future directions.
- 22 June 2022
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 10, 915312
Open AccessAutomated Oxygen Delivery in Neonatal Intensive Care
Oxygen is the most common drug used in the neonatal intensive care. It has a narrow therapeutic range in preterm infants. Too high (hyperoxemia) or low oxygen (hypoxemia) is associated with adverse neonatal outcomes. It is not only prudent to maintain oxygen saturations in the target range, but also to avoid extremes of oxygen saturations. In routine practice when done manually by the staff, it is challenging to maintain oxygen saturations within the target range. Automatic control of oxygen delivery is now feasible and has shown to improve the time spent with in the target range of oxygen saturations. In addition, it also helps to avoid extremes of oxygen saturation. However, there are no studies that evaluated the clinical outcomes with automatic control of oxygen delivery. In this narrative review article, we aim to present the current evidence on automatic oxygen control and the future directions.
- Open Access
- 17 June 2022
- Published by Springer Nature in BMC Pediatrics
- Vol. 22 (1) , 1-6
Frequency and duration of extreme hypoxemic and hyperoxemic episodes during manual and automatic oxygen control in preterm infants: a retrospective cohort analysis from randomized studies
Neonatal exposure to episodic hypoxemia and hyperoxemia is highly relevant to outcomes. Our goal was to investigate the differences in the frequency and duration of extreme low and high SpO2 episodes between automated and manual inspired oxygen control. Post-hoc analysis of a cohort from prospective randomized cross-over studies. Seven tertiary care neonatal intensive care units. Fifty-eight very preterm neonates (32 or less weeks PMA) receiving respiratory support and supplemental oxygen participating in an automated versus manual oxygen control cross-over trial. Extreme hypoxemia was defined as a SpO2 < 80%, extreme hyperoxemia as a SpO2 > 98%. Episode duration was categorized as < 5 seconds, between 5 to < 30 seconds, 30 to < 60 seconds, 60 to < 120 seconds, and 120 seconds or longer. The infants were of a median postmenstrual age of 29 (28-31) weeks, receiving a median FiO2 of 0.28 (0.25-0.32) with mostly receiving non-invasive respiratory support (83%). While most of the episodes were less than 30 seconds, longer episodes had a marked effect on total time exposure to extremes. The time differences in each of the three longest durations episodes (30, 60, and 120 seconds) were significantly less during automated than during manual control (p < 0.001). Nearly two-third of the reduction of total time spent at the extremes between automated and manual control (3.8 to 2.1% for < 80% SpO2 and 3.0 to 1.6% for > 98% SpO2) was seen in the episodes of at least 60 seconds. This study shows that the majority of episodes preterm infants spent in SpO2 extremes are of short duration regardless of manual or automated control. However, the infrequent longer episodes not only contribute the most to the total exposure, but also their reduction in frequency to the improvement associated with automated control.
- 17 June 2022
- Published by Springer Nature in BMC Pediatrics
- Vol. 22 (1) , 1-6
Open AccessFrequency and duration of extreme hypoxemic and hyperoxemic episodes during manual and automatic oxygen control in preterm infants: a retrospective cohort analysis from randomized studies
Neonatal exposure to episodic hypoxemia and hyperoxemia is highly relevant to outcomes. Our goal was to investigate the differences in the frequency and duration of extreme low and high SpO2 episodes between automated and manual inspired oxygen control. Post-hoc analysis of a cohort from prospective randomized cross-over studies. Seven tertiary care neonatal intensive care units. Fifty-eight very preterm neonates (32 or less weeks PMA) receiving respiratory support and supplemental oxygen participating in an automated versus manual oxygen control cross-over trial. Extreme hypoxemia was defined as a SpO2 < 80%, extreme hyperoxemia as a SpO2 > 98%. Episode duration was categorized as < 5 seconds, between 5 to < 30 seconds, 30 to < 60 seconds, 60 to < 120 seconds, and 120 seconds or longer. The infants were of a median postmenstrual age of 29 (28-31) weeks, receiving a median FiO2 of 0.28 (0.25-0.32) with mostly receiving non-invasive respiratory support (83%). While most of the episodes were less than 30 seconds, longer episodes had a marked effect on total time exposure to extremes. The time differences in each of the three longest durations episodes (30, 60, and 120 seconds) were significantly less during automated than during manual control (p < 0.001). Nearly two-third of the reduction of total time spent at the extremes between automated and manual control (3.8 to 2.1% for < 80% SpO2 and 3.0 to 1.6% for > 98% SpO2) was seen in the episodes of at least 60 seconds. This study shows that the majority of episodes preterm infants spent in SpO2 extremes are of short duration regardless of manual or automated control. However, the infrequent longer episodes not only contribute the most to the total exposure, but also their reduction in frequency to the improvement associated with automated control.
- 10 May 2022
- Published by Springer Nature
- p. 839-846
Discharge Planning and Follow-Up of the NICU Graduate
- 10 May 2022
- Published by Springer Nature
- p. 839-846
Discharge Planning and Follow-Up of the NICU Graduate